Arix Bioscience plc

CIK 00017004493 companiesMAYFAIR, LONDON, X0

SEC Profile

Transactions

Companies

Filings

CIK

0001700449

Recent Transactions

29 trades

Sale
LogicBio Therapeutics, Inc.
Common stock
2020-09-28$7.54/sh−273,584→ 2,381,436 total
Sale
LogicBio Therapeutics, Inc.
Common stock
2020-09-25$7.08/sh−174,219→ 2,655,020 total
Sale
LogicBio Therapeutics, Inc.
Common stock
2020-09-24$7.63/sh−38,514→ 2,829,239 total
Sale
LogicBio Therapeutics, Inc.
Common stock
2020-08-13$8.75/sh−159→ 2,867,753 total
Sale
LogicBio Therapeutics, Inc.
Common stock
2020-08-12$8.79/sh−1,335→ 2,867,912 total
Sale
LogicBio Therapeutics, Inc.
Common stock
2020-07-29$8.78/sh−2,709→ 2,869,247 total
Sale
LogicBio Therapeutics, Inc.
Common stock
2020-07-22$9.00/sh−22,651→ 2,871,956 total
Sale
LogicBio Therapeutics, Inc.
Common stock
2020-07-20$9.25/sh−36,983→ 2,894,607 total
Sale
LogicBio Therapeutics, Inc.
Common stock
2020-07-17$9.24/sh−31,101→ 2,931,590 total
Sale
LogicBio Therapeutics, Inc.
Common stock
2020-07-16$8.56/sh−16,332→ 2,962,691 total
Sale
Harpoon Therapeutics, Inc.
Common stock
2020-05-28$21.33/sh−366,591→ 2,193,704 total
Sale
Harpoon Therapeutics, Inc.
Common stock
2020-05-27$22.39/sh−12,064→ 2,560,295 total
Purchase
Enliven Therapeutics, Inc.$ELVN
Common Stock
2020-03-16$16.00/sh+187,500→ 1,554,558 total
Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2020-03-16+1,367,058→ 1,367,058 total
Conversion
Enliven Therapeutics, Inc.$ELVN
Series B Preferred Stock
2020-03-16−8,611,110→ 0 total
Sale
Harpoon Therapeutics, Inc.
Common stock
2019-12-17$16.83/sh−12,476→ 2,572,359 total
Sale
Harpoon Therapeutics, Inc.
Common stock
2019-12-16$17.02/sh−13,080→ 2,584,835 total
Sale
Harpoon Therapeutics, Inc.
Common stock
2019-12-13$17.21/sh−11,002→ 2,597,915 total
Sale
Harpoon Therapeutics, Inc.
Common stock
2019-12-10$16.91/sh−131,696→ 2,608,917 total
Sale
Harpoon Therapeutics, Inc.
Common stock
2019-12-09$18.12/sh−77,316→ 2,740,613 total
Sale
Harpoon Therapeutics, Inc.
Common stock
2019-12-09$18.30/sh−26,438→ 2,817,929 total
Sale
Harpoon Therapeutics, Inc.
Common stock
2019-12-06$19.15/sh−47,752→ 2,844,367 total
Conversion
Harpoon Therapeutics, Inc.
Common stock
2019-02-12+2,463,548→ 2,463,548 total
Purchase
Harpoon Therapeutics, Inc.
Common stock
2019-02-12$14.00/sh+428,571→ 2,892,119 total
Conversion
Harpoon Therapeutics, Inc.
Series B Convertible Preferred Stock
2019-02-12−1,720,698→ 0 total
Conversion
Harpoon Therapeutics, Inc.
Series C Convertible Preferred Stock
2019-02-12−742,850→ 0 total
Conversion
LogicBio Therapeutics, Inc.
Series B Preferred Stock
2018-10-23−4,352,775→ 0 total
Purchase
LogicBio Therapeutics, Inc.
Common stock
2018-10-23$10.00/sh+700,000→ 2,979,023 total
Conversion
LogicBio Therapeutics, Inc.
Common stock
2018-10-23+2,279,023→ 2,279,023 total

Companies

Recent Filings

Address

20 BERKELEY SQUARE

MAYFAIR, LONDON, X0, W1J 6EQ

View on SEC.gov